Orion Therapeutics Inc. is engaged in helping our clients discover and develop early-stage DNA/RNA therapeutics and vaccines by providing targeted, non-viral delivery systems that are safe and effective. The primary barrier to success of RNA and DNA clinical trials is the lack of an adequate delivery system. Our patented lipid nanoparticles are comprised of 100% natural components and incorporate dually functional lipopeptides during the nano formulation process for efficient loading and enhanced target cell delivery.